The goals of the CAPRELSA REMS Program are to mitigate the serious risks of QT prolongation, Torsades de pointes, and sudden death associated with use of CAPRELSA by:
- Educating prescribers on the following:
° Serious risks of QT prolongation, Torsades de pointes, and sudden death associated with use of CAPRELSA.
° The need to monitor for QT prolongation and electrolyte abnormalities.
° Appropriate management of QT prolongation to minimize the occurrence of Torsades de pointes and sudden death associated with use of CAPRELSA.
- Informing patients on the following:
° Serious risks of QT prolongation, Torsades de pointes, and sudden death associated with use of CAPRELSA